Institute for Clinical Immunology and Cell Therapeutics

Latest News from our Institute

Professor Fricke elected GC‑I³ spokesperson

27.10.2026 -

Clinical immunology meets cell and gene therapy development: Professor Stephan Fricke takes on the role of GC-I³ spokesperson.

more ...

ATLAS: Advancing Manufacturing Processes for Innovative Cell and Gene Therapies

26.10.2026 -

The Institute of Clinical Immunology and Cell Therapeutics (IKIZ), through its tAMPi Research Group, is participating in the ATLAS project led by the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig as part of the SaxoCell consortium.
The project focuses on regulatory and quality assurance requirements for the manufacturing of advanced therapy medicinal products (ATMPs), particularly within the framework of the Hospital Exemption under Section 4b of the German Medicinal Products Act (AMG).

more ...

Autumn University 2026: Exploring Medicine and Immunology

21.10.2026 -

On 21 October 2026, 20 school students will take part in the Autumn University programme at the Faculty of Medicine. The programme includes a welcome session with information about degree programmes and the admissions process, followed by a mini selection test. Participants will also attend a lecture in medical sociology and visit the MAMBA skills lab. After a shared lunch break, they will receive a safety briefing and take part in an immunology experiment. The day will conclude with an evaluation of the mini selection test, an award presentation and, if appropriate, a group photo. The students will be accompanied throughout the day by immunology master's students.

 

more ...

OPTI-CART: AI-assisted platform for the systematic analysis and optimization of CAR T cells

13.08.2026 -

OPTI-CART combines experimental analyses of CAR T-cell signaling and molecular interaction networks with AI-assisted computational approaches. The aim is to identify key features associated with high-performing CAR T cells and to derive strategies to further improve their functionality.

more ...

Best Poster Presentation Award at the yEFIS Conference 2026 in Prague

01.07.2026 -

 

Nouria Jantz (a PhD candidate in the Kahlfuß and Müller research groups at the Institute of Clinical Immunology and Cell Therapeutics) has won the Best Poster Presentation Award at this year's Young European Federation of Immunological Societies (yEFIS) Conference in Prague.

more ...

Master's thesis forms the basis for a publication in the renowned European Journal of Immunology

17.06.2026 -

The Simeoni group Institute of Clinical Immunology and Cell Therapeutics (Director: Prof. Dr. S. Fricke) has published a technical report in European Journal of Immunology comparing CD3/CD28 and PMA/ionomycin stimulation in primary human T cells. The study shows that these activation models are not interchangeable, as PMA/ionomycin induces strong IL-2 production and CD25 expression but only weak IL-2R/STAT5 activation. The work provides important methodological guidance for T-cell activation studies and while simultaneously highlighting the successful transition from a master's thesis to a publication in a renowned immunology journal.

more ...

Poster Prize for Leon-Alexander Dewitz at the EMBO Workshop “Pathogen Immunity and Signalling”

12.06.2026 -

Leon-Alexander Dewitz, PhD student at the Institute of Clinical Immunology and Cell Therapeutics (Director: Prof. Dr. Stephan Fricke), received the Science Journal Poster Prize at the international EMBO Workshop “Pathogen Immunity and Signalling” (08.–12.06.2026, Leiden). His research investigates the role of pyroptosis during Leishmania major infection using genetically encoded biosensors.

more ...

Students visit for 15th Boys‘ Day

23.04.2026 -

As part of the 15th Boys' Day, students gained an exciting insight into the laboratory work and research at the Institute for Clinical Immunology and Cell Therapeutics (IKIZ).

more ...

Last Modification: 21.07.2026 - Contact Person:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: